Neuroblastoma in southern Brazil: An 11-year study

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 2, 2006, Pages 82-87

  Parise, Ivy Zortéa S ^a,b   Haddad, Bassem R ^c   Cavalli, Luciane R ^c   Pianovski, Mara A D ^a,b,d   Maggio, Ewerton M ^b   Parise, Guilherme A ^b,e   Watanabe, Flora M ^e   Ioshii, Sérgio O ^d   Rone, Janice D ^c   Caleffe, Luiz Gonzaga ^f   Odone Filho, Vicente ^g   Figueiredo, Bonald C ^a,b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Center for Molecular Genetics and Cancer Research in Children (CEGEMPAC)   (Brazil)

^c GEORGETOWN UNIVERSITY   (United States)

^d Hospital Erasto Gaertner   (Brazil)

^e HOSPITAL PEQUENO PRÍNCIPE   (Brazil)

^f FACULDADE EVANGÉLICA DO PARANÁ   (Brazil)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Child; Delayed diagnosis; MYCN; Neuroblastoma; Prognosis

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; TENIPOSIDE; VINCRISTINE;

ARTICLE; BRAZIL; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHILD HOSPITALIZATION; CHILDHOOD CANCER; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TIME SERIES ANALYSIS;

ADOLESCENT; AGE OF ONSET; BRAZIL; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EARLY DIAGNOSIS; FEMALE; GENES, MYC; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NEUROBLASTOMA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33644618749     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000199601.35010.52     Document Type: Article

References (28)

1. Blatt J, Wharton V. Stimulation of growth of neuroblastoma cells by ferritin in vitro. J Lab Clin Med. 1992;119:139-142.
2. Brodeur GM. Molecular basis for heterogeneity in human neuroblastomas. Eur J Cancer. 1995;31A:505-510.
3. Look AT, Hayes FA, Schuster JJ, et al. Clinical relevance of tumor cell ploidy and MYCN gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. 1991;9:581-591.
4. Castleberry RP, Pritchard J, Ambros P, et al. The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer. 1997;33:2113-2116.
5. Goto S, Umehara S, Gerbing RB, et al. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors. Cancer. 2001;92:2699-2708.
6. Westwermann F, Schwab M. Genetic parameters of neuroblastomas. Cancer Lett. 2002;184:127-147.
7. Schwab M. MYCN in neuronal tumors. Cancer Lett. 2003;249:179-182.
8. Seeger RC, Broudeur GM, Sather H, et al. Association of multiple copies of the MYCN oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985;313:1111-1116.
9. Brodeur GM, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams & Wilkins, 2002:895-937.
10. Godfried MB, Veenstra M, Valent A, et al. Lack of interstitial chromosome 1p deletions in clinically detected neuroblastoma. Eur J Cancer. 2002;38:1513-1519.
11. Ries LAG, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents: SEER Program 1975-1995, National Cancer Institute, 1999. http://www-seer.ims.nci.nih.gov (accessed Dec. 22, 2004).
12. Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer. 1999;86:364-372.
13. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466-1477.
14. Castleberry RP. Biologia e tratamento do neuroblastoma. In: Clínicas Pediátricas da América do Norte. Philadelphia: WB Saunders, 1997;4:927-941.
15. Cullen KJ, Newkirk KA, Schumaker LM, et al. Glutathione-S-transferase π amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res. 2003;63:8097-8102.
16. Haddad B, Pabon-Pena C, Young H, et al. Fine mapping of STAT1 gene by FISH and radiation hybrids. Cytogenet Cell Genet. 1998;83:58-59.
17. Cochran WG, Cox GM. Experimental Designs, 2nd ed. New York: John Wiley & Sons, 1957.
18. De Bernardi B, Nicolas B, Boni L, et al. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-operative Group for Neuroblastoma. J Clin Oncol. 2003;21:1592-1601.
19. Woods WG, Tuchman M, Bernstein JM, et al. Screening for neuroblastoma in North America. 2-year results from the Quebec Project. Am J Pediatr Hematol Oncol. 1992;14:312-319.
20. Brodeur GM, Maris JM, Yashiro DJ, et al. Biology and genetics of human neuroblastoma. J Pediatr Hematol Oncol. 1997;19:93-101.
21. Shen L, Wu Z, Kuroda T, et al. Clonality analysis of childhood neuroblastoma by polymerase chain reaction for the human androgen receptor gene. Int J Oncol. 2005;26:1329-1335.
22. Matthay KK, Perez C, Seeger RC, et al. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. J Clin Oncol. 1998;16:1256-1264.
23. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999;341:1165-1173.
24. Pianovski MA, Maluf EMCP, Carvalho DS, et al. Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil. Pediatr Blood Cancer. 2005;Sep. 30 [e-pub ahead of print].
25. Sartelet H, Grossi L, Pasquier D, et al. Detection of MYCN amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR. J Pathol. 2002;198:83-91.
26. Pérel Y, Valteau-Couanet D, Michon J, et al. Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use. Arch Pediatr. 2004;11:834-842.
27. Rubie H, Hartmann O, Michon J, et al. MYCN gene amplification is major prognostic factor in localized neuroblastoma: results of French NBL 90 study. J Clin Oncol. 1997;15:1171-1182.
28. Pollock BH, Krischer JP, Vietti TJ. Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr. 1991;119:725-732.